Three Georgia companies and their principals have been banned from continuing their "bogus claims" that their stem cell ...

The heart’s natural healing ability is limited but groundbreaking research and advanced therapies are offering new hope for ...

A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer.

Caregiving can take many forms, often requiring a profound shift in daily life. While navigating a disease is an immense challenge for patients, managing the emotional, logistical and personal burdens ...

In blood cancers such as chronic lymphocytic leukemia, B cells of the immune system multiply uncontrollably. One form of ...

David Sallman, MD, Moffitt Cancer Center, discussed the trial's impact and the future role of MRD monitoring in treatment ...

Russell W. Jenkins, MD, PhD, a physician investigator in the Krantz Family Center for Cancer Research at the Mass General ...

Prostate cancer is usually treated with surgery and radiation therapy, but these can have drastic side effects. A new ...

A new study has introduced an innovative approach to CAR-T therapy that could address some of the current challenges in ...

The company has three clinical CAR-T programmes backed by its precision-targeting cellular system Imod platform technology.

A groundbreaking study from Baylor College of Medicine explores how two types of CAR T cells target cancer, shedding light on ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...